Pharmaceutical Technology reported the BeOne New Jersey expansion in August 2026. The project includes a new three-story building. The building will span approximately 145,000 square feet. About 120 additional full-time positions are expected. The site workforce is expected to reach nearly 240.
BeOne Adds a 145,000-Square-Foot Building
BeOne’s expansion includes a new three-story building spanning about 145,000 square feet, increasing the physical scale of its New Jersey manufacturing and research operations. This evidence supports focused pharmaceutical career decisions today. This evidence supports focused pharmaceutical career decisions today.
About 120 Full-Time Roles Are Expected
The project is expected to create roughly 120 additional full-time positions, giving job seekers a measurable employment signal tied directly to a defined facility. This evidence supports focused pharmaceutical career decisions today. This evidence supports focused pharmaceutical career decisions today.
With the additional roles, Pharmaceutical Technology says the site workforce could approach 240, meaning the project would materially increase employment at the location. That context helps readers make more focused career decisions. This evidence supports focused pharmaceutical career decisions today.
Manufacturing and R&D Expand Side by Side
Manufacturing and R&D are expanding together, creating a site where development work and operational execution can interact as programs move toward larger-scale or commercial. This evidence supports focused pharmaceutical career decisions today. This evidence supports focused pharmaceutical career decisions today.
New Jersey Gains Another Biopharma Growth Project
For candidates, New Jersey gains another visible biopharma expansion project, but specific openings, qualifications, timing, and functions should be confirmed through BeOne’s official recruitment. This evidence supports focused pharmaceutical career decisions today. This evidence supports focused pharmaceutical career decisions today.
R&D Growth Needs Scalable Quality Support
R&D expansion needs quality support that can scale with new laboratories, methods, materials, records, and development activities while maintaining controlled practices appropriate to each. This evidence supports focused pharmaceutical career decisions today. This evidence supports focused pharmaceutical career decisions today.
Manufacturing growth can increase validation workload across equipment, utilities, computerized systems, processes, and cleaning, particularly as new areas transition from construction into operational use. This evidence supports focused pharmaceutical career decisions today. This evidence supports focused pharmaceutical career decisions today.
QC Capability Must Match Manufacturing Scale
QC laboratory capacity must align with manufacturing output, sampling, methods, stability work, release testing, and investigations. Actual staffing needs depend on the processes planned for the site. The source therefore provides a practical reference point for current pharmaceutical career planning.
Engineering Enables Facility and Equipment Readiness
Engineering teams help translate facility design into reliable operations through commissioning, maintenance, utilities, automation, equipment readiness, and technical troubleshooting during start-up and routine production. This evidence supports focused pharmaceutical career decisions today. This evidence supports focused pharmaceutical career decisions today.
To connect BeOne’s New Jersey manufacturing and R&D expansion with role-specific technical preparation, read Pharmuni’s Pharma Validation Jobs Search Guide in 2026: Roles, Skills. It explains process validation, equipment qualification, cleaning validation, CSV, IQ/OQ/PQ, PPQ, and the skills candidates can demonstrate when targeting validation-intensive sites.